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Abstract:  An observational and experimental study was conducted to see the proportion of overlap 
between the clinical and laboratory diagnosis of pneumonia and malaria and the therapeutic 
effectiveness of cotrimoxazole.  Children under five years  who presented to the clinic with  fever 
and/or cough or difficulty in breathing were enrolled in the study. Blood smears were done for all 
enrolled children while chest x-rays were obtained only for those children with parasitaemia or who 
met the clinical case definition for pneumonia.  There were  736 children who met the clinical case 
definition of malaria, while 731 met the clinical case definition of pneumonia.  Of these two groups, 
456 (61.9%) of children with clinical malaria and 62.3% of those with clinical pneumonia represent 
the overlap of children who met both clinical definitions. Specific clinical definition did not 
differentiate pneumonia and malaria.  A single treatment of both diseases by cotrimoxazole is 
showed to be as effective as a combination of treatment with chloroquine and procaine penicillin.  
Parasite clearance was better in the cotrimoxazole group than the chloroquine-penicillin group, 
however the cotrimoxazole group had a higher rate of recurdescences with two  out of 41 patients 
smear positive at day 14. A significant  proportion of overlap in the clinical and laboratory diagnosis 
of pneumonia and malaria is shown and that a three days cotrimoxazole therapy is equally effective 
in treating both diseases as a combination of chloroquine and procaine penicillin is. [Ethiop. J. 




   Pneumonia and malaria are the major causes of mortality and morbidity among children in 
developing countries including Ethiopia (1-5).  
   Malaria treatment is recommended for a child living in a malaria endemic area, where microscopy 
is not available if the child has fever or  history of fever with no other obvious cause. In highly 
malarious areas, malaria treatment is advised for all children with fever whether or not other obvious 
causes are present (6).  Treatment for bacterial pneumonia is recommended for any child with cough 
or difficulty in breathing who has a high respiratory rate or lower chest wall indrawing(7).  
   Studies conducted in several countries indicate that there is a significant overlap in the clinical 
presentation of pneumonia and malaria (8-11). Case management algorithms are based on the 
premise that a child is likely to have only one disease at a time.  Thus a child with fever and cough 
may meet clinical case definition for both malaria and pneumonia but have only one disease, or none 
at all and yet receive one or two treatments unnecessarily.  Conversely a child may have both disease 
but be assessed and treated for only one.  
   Cotrimoxazole, which has a similar effect of pyrimethamine/sulfadoxine (fansidar), is known to 
be an effective antimalarial in adults and children over 5 years of age.  Because of its broad   
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Health, Faculty of Medicine, P.O. Box 1176, Addis Ababa. spectrum efficacy, low cost, ease of 
administration and low incidence of adverse effects, cotrimoxazole is the preferred drug in most 
settings for out patient treatment of bacterial pneumonia.  A study of subjects with falciparum 
parasitaemia in Tanzania (12), Mozambique (13) and vivax malaria (14), have reported 
cotrimoxazole as being  effective as chloroquine.  
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   Better definition of the patterns in the clinical presentation of these diseases is needed to permit 
more effective diagnosis and treatment.  Documentation that a single drug is effective against the 
pathogens of both diseases could both save money and avert  deaths.   
   This paper is a report of a study which was designed to define the overlap in the clinical 
presentation of pneumonia and malaria and to determine the response to cotrimoxazole treatment of 
children with these diseases.  
  
Methods  
   An observational and experimental study (a randomized, double-blind clinical trial) was conducted 
between September to December 1993 when rates of pneumonia and malaria reach a maximum, 
according to reviews of health institutions records.  
   The study was conducted in the two health centres and one hospital located in Awassa Town. 
Awassa Zuria district has an area of 1875 sq.km with a total population of 307,767.  Approximately  
23% of the population is urban, and children under five years of age account for 19% of the total.  
The majority of the population are farmers, and 75% live at altitudes ranging from 500-3500 m.  
Awassa lake is found in the northwest central part of the district with an area of 129 sq.km and 
average depth of 10 metres.  Most of the area are Kola with annual temperature ranging from 4.5 to 
34 degree centigrade.  There are two rainy seasons in the area, one with heavy rainfall in the month 
of July to September and the other with light rainfall from January through March.  The annual 
rainfall averaged 1110 mm.  
   A nurse asked each mother or other care taker why the child had been brought to the clinic, and up 
to three reasons were recorded for each child.  Every child brought to the clinic because of fever 
and/or cough or difficulty in breathing whose mother gave verbal informed consent for participation, 
was enrolled in the study.  Children with severe cases of pneumonia and malaria or those who had 
any history of taking antimalarial medication in the past two weeks were considered ineligible for 
the clinical trial.  
   At enrolment, care-takers were interviewed to obtain data including the name, address, age, sex, 
history of fever, cough, difficulty in breathing, rapid breathing and any medication taken, physical 
examination and laboratory tests.  
   The axillary temperature was taken using an ordinary mercury thermometer for at least one minute 
and respiratory rate was counted for one full minute when the child was calm or undisturbed. Weight 
and height were measured using a standard scale in the health institutions.  Using the clinical history 
and physical findings, the children were categorized into groups based on whether they met the 
clinical definition of malaria and/or pneumonia.  
   After the clinical diagnosis was recorded, the children under-went laboratory investigation.  
Haemoglobin in gm/100dl was determined for all children using Sahel's method.  Thick and thin 
blood films of all enrolled children were made and stained with Giemsa, then examined under oil 
immersion.  Asexual forms of plasmodium were typed and their density assessed by counting against 
200 white blood cells.  Densities were expressed as parasites/mm3 assuming 8000 WBC/mm3 of 
blood.  Blood films were reported as negative only after examination of 100 high power fields.  Chest 
radiography was performed only for  children with parasitaemia or for those meeting the clinical 
definition of pneumonia.  Children who didn't have malaria parasitaemia and who didn't have 
radiography were assumed to have negative chest radiographs.  Laboratory technicians and 
radiologists were not aware of the clinical diagnosis and were not allowed to see any child before 
completing diagnostic tests.   
   Based on results of the laboratory and chest x-ray investigation, patients were given final diagnosis.   
Mothers or other caretakers of children with both laboratory diagnosed malaria and radiographically 
diagnosed pneumonia were invited to be participants in the clinical trial.  Participating children were 
randomly allocated into the two treatment groups using table of random numbers.  
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    Group one received cotrimoxazole at standard dosage (trimethoprim 6mg/sulphamethoxazole 
30mg/kg body weight in two divided doses daily, administered orally as syrup, crushed powder or 
tablets) for three days.   
   Group two received the standard regimen of chloroquine base (10mg chloroquine phosphate 
base/kg of body weight followed by 5mg/kg 6-8 hours later and 5mg/kg on each of the second and 
third days orally as syrup, crushed powder or tablets) and procaine penicillin at a dose of 50,000 
units/kg body weight intramuscular daily for five days.   
   All patients were invited for a return visit on the 7th and 14th days after initiation of treatment.  To 
improve compliance, the cost of medication, investigation and transportation were covered by the 
research fund and it was explained that the child would be seen at each visit with the minimum of 
waiting time.  
   During each follow up visit, parents were asked about the compliance with the medication regimen 
and whether their child had been ill or had experienced fever, cough, difficulty in breathing, 
vomiting, diarrhoea or poor appetite.  The child was examined for the presence of chest indrawing 
and other danger signs.  The temperature and respiratory rates were recorded and blood film 
performed.    
   Malaria therapy was considered to have been successful if no parasites were detected on day seven 
and 14.  All patients with parasitaemia on day seven were treated with a single dose of Fansidar 
(25mg pyrimethamine and 500 mg sulfadoxine).  
   A child was considered ill if he or she had fever and/or one more symptom of vomiting, diarrhoea, 
cough or loss of appetite or three of these symptoms without fever.  The overall condition was 
recorded as worsened, same or improved.  
   Clinical malaria was diagnosed in the presence of a fever or history of fever.  Fever was defined 
as an axillary temperature of 37.5 or more.  Clinical pneumonia was diagnosed in the presence of 
chest indrawing, cough or difficulty in breathing with a rapid breathing rate of 60 per minute or more 
for children less than two months of age; 50 or more breathe for children 2-11 month of age; and 40 
or more for children 12 months of age or older. Severe pneumonia was diagnosed if chest indrawing 
was present.  
    
Table 1:  
General characteristics of the study population, Awassa (southern Ethiopia) 1993.    
Characteristics  Number (%) 
1. Sex    
male  601 (54.5)  
Female  492 (45.5)  
2. Age (months)    
0-12  439 (40.2)  
25 - 36  212 (19.4)  
37 - 48  158 (14.4)  
49 - 60  152 (14.4)  
3. History of medication    
Antimalarial  243 (22.2)  
Antibiotic   13 (1.2)     
Procaine penicillin   98 (9.0)  
Chloramphenicol   41 (3.8)  
Bacterium    1 (0.1)  
Ampicillin    4 (0.4)  
Other   51 (4.7)  
    Others    1 (0.1)  
4. Smear positive    253 (23.1)  
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    Type of plasmodium    
Falciparum   88 (34.8)  
Vivax      165 (65.2)  
    Parasite density    
1 - 4999       87 (34.4)  
5000 - 9999     99 (39.1)  
10000 - 14999     29 (11.5)  
15000 - 19999     12 (4.74)  
> 20000       26 (10.5)  
5. Nutritional status    
Stunted      282 (25.8)  
Under weight    230 (21.0)  
Wasted    228 (20.9)       
   Laboratory diagnosis of malaria was made in presence of asexual parasites in the blood smear.  
Cases of severe malaria included those children with parasite density exceeding 250,000/ mm3 and 
with a haemoglobin level of 7.5gm/100ml or less. Radiographic pneumonia was defined as the 
presence of parenchemal density compatible with pneumonia as interpreted by the radiologist.  
Radiographs showing lobar consolidation or involvement of more than one lobe were classified as 
severe.  
   The Epi Info (version 5) and the Statistical Analysis System (SAS, version 6.04) programs were 
used to analyse the data collected. Data on the parasite density were transformed to natural logarithm 
scale before they were used in statistical analysis.   
   Parents/care takers of the potential children for the study were informed about the aims, methods, 
anticipated benefits and potential hazards of the study and verbal consent was obtained.  Severe 
cases of either pneumonia or malaria were admitted and treated appropriately and considered 
ineligible for the clinical trial. The study was approved by both  a review committee of the 




   A total of 1093 children were enrolled in the study. A summary of the general characteristics of 
the study population at the time of entry into the study is summarized in Table 1.  The average age 
of children enrolled was 25 months.  
   Of the total children enrolled, fever, cough or difficulty in breathing or  both were reported in 305 
(27.9%), 218 (19.9%) and 570 (52.2%) of the children by mothers or other care takers, respectively. 
The parasite densities ranged from 130 to 320000, but only three cases had a parasite density of 
more than 100,000.  Among those who had history of taking procaine penicillin and ampicillin, 22% 
and 7.8%, respectively, and also 14.8% of those taking other medication were found positive for 
plasmodium.  Of 13 who had history of taking antimalarial two (15.4%) had positive smears, of 
which one was falciparum and the other vivax malaria.  
   Of the total of 843 children who had radiographic investigation, 403 (47.8%) had positive findings. 
Among these, 33 (8.2%) were severe pneumonia, 360 (89.3%) none severe, and 10 (2.5%) had other 
diagnosis.   Among those who had history of taking antibiotic, 38.8% were found to have 
radiographic pneumonia, while 15.4% of those who had taken antimalarial had radiographic 
pneumonia. Six  children who had history of taking injections of procaine penicillin were found to 
have both radiographic pneumonia and parasitaemia.  
   There was significant overlap in clinical as well as laboratory diagnosis of pneumonia and malaria.  
The clinical definition of both pneumonia and malaria was met by 456 (41.7%) children (Table 2).   
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Table 2:  Number of children under five with fever and/or cough or difficulty in breathing meeting clinical and laboratory 
definition for malaria and pneumonia, Awassa (southern Ethiopia) 1993.  
  
   Clinical             Number (%)       Laboratory       Number (%)  
  
1.Malaria alone      280 (25.6)         a. Malaria    81 (28.9)  
    b. Both         14 (5.0)  
    c. Neither    185 (66.1)  
    Total             280 (100)  
2.Pneumonia alone    275 (25.2)     a.  Malaria         11 (4.0)  
     b. Pneumonia   107 (38.9)  
    c. Both                15 (5.5)  
     d. Neither          142 (51.6)  
     Total                  275 (100)  
3.Both                     456 (41.7)     a. Malaria         50 (10.9)  
     b. Pneumonia  176 (38.6)  
    c. Both               81 (17.8)  
    d. Neither          149 (32.7)  
    Total                 456 (100)  
4.Neither                   82 (7.5)  Neither  82  
      Total               1093(100)                 
   Children who satisfied the clinical definition for both pneumonia and malaria were more likely to 
have radiographic pneumonia (OR=4.76, 95%CI: 3.62-6.26), parasitaemia (OR=1.75, 95%CI: 
1.312.35) and both at the same time (OR=4.53, 95%CI: 2.85-7.23) than children who do not meet 
the definition.  
   A total of 107 out of 283 (37.8%) with radiological signs consistent with pneumonia and a negative 
blood film, and 15 out of 110 (13.0%) with radiological signs consistent with pneumonia and a 
positive blood film, satisfied the clinical case definition for pneumonia.    
   However 61 out of 142 (43.0%) of those satisfying the clinical case definition of malaria with a 
positive blood film and no radiological evidence of pneumonia, also satisfied the clinical case 
definition of pneumonia.  
   The likelihood of radiographic pneumonia was higher in  smear positives than smear negatives 
(OR=1.53, 95%CI: 1.15-2.04).  There was no difference observed in relation to age, sex, 
haemoglobin, nutritional status, type of parasite or parasite density.   
   The comparability of the children in the two treatment groups is demonstrated in Table 3.  There 
was no significant difference in their general characteristics except for weight-for-height z-scores.   
Only three children were lost in the follow up.   
  
Table 3:  General characteristics of the treatment groups, Awassa (southern Ethiopia) 1993.  
  GROUP-1       GROUP-2         P-VALUE  
Number of children     42                 52    
1. Age                mean ± sd   28 ± 17.6       31 ± 17.7           p=0.60  
2. Sex      Male     20  29    
               Female  22      43  p=0.43  
3. Temperature        Febrile  35  44    
                          Afebrile  7  8  p=0.87  
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4. Haemoglobin          
mean ± sd    8.68 ± 1.27    8.7 ± 0.88          p=0.91  
5. Nutritional status        
mean ± sd  HAZ        -0.31 ± 1.92     -0.59 ± 2.06       P=0.50  
WAZ  -1.42 ± 1.40     -1.03 ± 1.29       P=0.17  
WHZ    -1.41 ± 1.13     -0.65 ± 1.69       P=0.01  
6. Density          
     log.mean ± sd    3.823 ± 0.369  3.914 ± 0. 481  p=0.30  
7. Type               Falciparum   16   23    
Vivax     26               29  p=0.55  
  
  
Treatment in group-1 = Cotrimoxazole; group-2 = Chloroquine + Procaine WHZ= Weight-for-
height z-scores; WAZ= Weight-for-age z-scores; WHZ= Height-for-age z-scores.  
  
   During the first scheduled follow up visit on the 7th day of treatment, those taking cotrimoxazole 
alone had a higher risk of fever and fast breathing but had less risk of having cough, vomiting, 
diarrhoea or  smear positivity than those taking procaine penicillin and chloroquine.  The proportion 
of children who clinically improved was higher in group-1 than group-2, although the difference 
was not statically significant (Table 4).  
   At the time of the second follow up visit on day 14, those treated with cotrimoxazole had a higher 
risk of fever, vomiting,  diarrhoea and positive blood smears than the chloroquine and penicillin 
treatment group, although the difference was not statiscally significant.  The two cotrimoxazole 
treated children who were smear positive had vivax malaria (Table 5).   
  
Discussion  
   Malaria transmission in the study area is perennial with peak incidence at the end of heavy rains 
from June to August.  In the study year, lower average rainfall than  previous years was associated 
with a low prevalence of positive smears of 23.1%. P.vivax was found to be the predominant species, 
accounting for 65% of cases detected. Radiographic pneumonia, on the other hand, was recorded in 
a larger proportion (25.8%) of children enrolled in the study than might have been expected based 
on data from previous years.   
   Health institutions in the district treat cases of pneumonia and malaria empirically based on history 
and physical examination.  Study findings suggest that at least 13% of those treated with antibiotics 
suffer from untreated malaria and 15% of those treated for malaria have undetected and untreated 
pneumonia.  
   A study in Malawi (9) evaluated children under five years of age with cough or fever brought to 
the outpatient department of Kamuzu Central Hospital in Lilogwa.  Of 1599 enrolled children, 566 
(35%) had parasitaemia and 116 had radiographic evidence of pneumonia; 43 had both radiographic 
pneumonia and parasitaemia.  Of the 471 children who met the clinical definition for pneumonia, 
449 (95%) also met the malaria clinical definition.  Among children with radiographic evidence of 
pneumonia, the clinical definition for malaria was not predictive of parasitaemia (sensitivity 93% 
and specificity 5%).  Whether malaria parasitaemia was present or absent, the pneumonia clinical 
definition distinguished children with and without radiographic evidence of pneumonia (sensitivity 
and specificity > 60%).  Children who satisfied the pneumonia clinical definition were more likely  
to have radiographic evidence of pneumonia (OR = 10.4, 95% CI: 5.2-20.7), parasitaemia (OR = 
1.6, 95% CI: 1.2-2.2) or both at same time (OR =4.2, 95% CI: 2.1-8.4) than were children who did 
not meet the clinical definition.  
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Table 4:  Response to treatment in the first week of follow up, Awassa (southern Ethiopia) 1993.  
  GROUP-1     GROUP-2     Relative Risk (95% CI)  
Number of children        42           49    
1.Fever                 8 (19.0)   5 (10.2)    1.87 (0.66-5.27)  
2.Cough               2 (4.8)   5 (10.2)    0.47 (0.10-2.28)  
3.Vomiting            1 (2.4)   5 (14.3)    0.23 (0.03-1.92)  
4.Diarrhoea          4 (9.5)   7 (14.3)    0.67 (0.21-2.12)  
5.Temperature     Febrile     6(14.3)  4 (8.2)      1.75 (0.53-5.79)  
 6.Fast breathing         1(2.4)     0               =      =  
7.Smear Positive  (2.4)       3 (6.1)      0.39 (0.04-3.60)           
8 .Condition        
        Same             1 (2.4)   3 (6.1)    
    Improved        4  1            46  0.39 (0.04-3.60) 
Treatment in group -1 = Cotrimoxazole        
                 group-2 = Chloroquine + Procaine  
  
   In the Gambia (10) a community based study of respiratory diseases in the eastern region 
monitored all under-five children in seven rural villages for respiratory complaints and febrile 
illness.  Children were enrolled in the study if they had rapid respiratory rate and based on the 
mothers subjective impression that the child was ill.  Those children with cough or fever but no fast 
breathing and children with chest indrawing but no fast breathing were not enrolled.  
   The study showed that 775 children (99.0%) satisfied the clinical case definition of malaria and 
665 (84.9%) children satisfied the clinical case definition for pneumonia.  Of those who met the 
clinical case definition for pneumonia 659 (99.0%) also satisfied the clinical case definition of 
malaria.  Of 134 children with radiographic sign of pneumonia and negative blood films, 129 
(97.0%) satisfied the clinical case definition for pneumonia.  Of 107 children with radiographic signs 
of pneumonia and a positive blood film, 91 (85.0%) satisfied the clinical case definition for 
pneumonia.  However, of 410 children with clinical and laboratory diagnosis of malaria but with 
negative radiographs, 326 (79.5%) also satisfied the clinical case definition of pneumonia. 
Parasitaemia was present in 520 (66.4%) of the 783 children with raised respiratory rate, and in 418 
(62.9%) of the 665 who satisfied the clinical case definition of pneumonia.  Only 107 (44.4%) out 
of 241 children with radiographic pneumonia had parasitaemia whereas 413 (76.2%) of 542 children 
with no radiological evidence of pneumonia had parasitaemia. Malaria parasitaemia of 5000/ mm3 
and over was associated more often with abnormal chest x-ray findings in this group of children than 
would be expected by chance.  
   Like the Malawi and Gambia studies, our study showed a significant proportion of overlap in 
pneumonia and malaria case definitions.  The overlap in clinical definitions of pneumonia and 
malaria of over 60%  is lower than that found in the Malawi and Gambia studies.  This difference 
could be due to the lower rate of parasitaemia and predominance of vivax malaria in this study when 
compared to the other studies. The overlap in laboratory diagnosis of both parasitaemia and 
radiographic pneumonia was similar to that found in the Mozambique study.  
   In contrast to the study in Malawi, our investigation revealed no reduced incidence of parasitaemia 
in the presence of radiographic pneumonia. In addition, radiographic pneumonia  was more often 
detected in this study, though not in Malawi, among those who met the clinical case definition for 
pneumonia when the smear was negative than positive.  But the findings of this study were similar 
to those in the Gambia, where radiographic pneumonia was more often detected among those who 
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met the clinical case definition of pneumonia when they were smear negative than when they were 
smear positive.  
   However, the overall likelihood of radiographic pneumonia was higher for smear positive than 
smear negatives.  This relationship was unaffected by differences in age, sex, haemoglobin, or 
parasite type and density.  This result contrasts with findings of previous studies.   
  
Table 5:  Response to treatment in the second week of  follow up, Awassa (southern Ethiopia) 1993.  
  GROUP-1     GROUP-2     Relative Risk (95% CI)  
Number of children      41            
 46    
1.Fever                3 (7.3)      2 (4.4)     1.68 (0.30-9.58)  
2.Cough               0              1 (2.2)         = =         
3.Vomiting            2 (4.9)       0               =   =  
4.Diarrhoea          4 (9.8)       3 (6.5)    1.50 (0.36-6.29)  
5.Temperature     Febrile     2 (4.9)      2 (4.4)    1.12 (0.17-7.61)  
 6.Fast breathing         0              0             = =           
7.Smear Positive  2 (4.9)      0             =   =  
8 .Condition        
        Same            2 (4.9)       0    
    Improved        39            46             = =   
* Treatment in group -1 = Cotrimoxazole      
                    group-2 = Chloroquine + Procaine  
  
   A facility-based study in Nigeria (8) evaluated the risk of malaria with bacteraemia in preschool 
children.  Six hundred and forty two febrile preschool children without localizing signs were found 
to have a prevalence of bacteraemia which was comparable in those with malaria (43/446, 9.6%) to 
those without malaria (24/196, 12.2%, p < 0.5). In Mozambique a study was conducted among 220 
children between two, four  months and four years of age admitted with the diagnosis of pneumonia 
(11).  Of 220 children with pneumonia, 19 (8.6%) also had P.falciparum parasitaemia.  Among those 
with parasitaemia 12 (63%) were classified as having severe pneumonia.  The  19 children with 
pneumonia and parasitaemia had a longer mean duration of cough and fever before admission (5.5 
days compared to two days ).  
   The study in Nigeria showed a higher prevalence of both malaria and bacteraemia among anaemic 
infants while the study in Mozambique documented lower haemoglobin levels among children with 
pneumonia and malaria.  In the study in the Gambia, chest x-ray changes were associated with higher 
parasite densities while in Nigeria, no correlation was observed between parasite density and overlap 
of pneumonia and malaria (8-11).  
   The specificity of the clinical definitions of malaria and pneumonia were not adequate to 
differentiate between the two diseases.  Inclusion of other additional criteria to improve the 
specificity of the clinical definition might reduce over treatment, but would still not permit 
pneumonia to be distinguished clinically from malaria.  The presence of a palpable spleen in malaria 
and crepitation in pneumonia increased the predictive value of the case definitions, but these findings 
were present in only a small proportion of the cases. This study was similar to previous studies in 
finding a low predictive value of fever in pneumonia, while maternal reports of fast or difficult 
breathing were better predictors of the presence of pneumonia.  
   Cotrimoxazole was found to be as effective in the treatment of malaria as chloroquine.  All patients 
in both groups had a statistically significant response.  Parasite clearance rates were better in the 
cotrimoxazole than the chloroquine group, however the cotrimoxazole group had the highest rate of 
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recurdescenses.  This finding is similar to that of the Tanzania and Mozambique studies, which 
showed a higher rate of recurrence with cotrimoxazole despite an effectiveness in parasite clearance 
equal to that of chloroquine.  
   The chloroquine group was less likely to have persistent fever, though more likely to have 
gastrointestinal complaints. Further studies are needed to assess chloroquine resistance in the area.  
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   In conclusion, the study shows a significant  proportion of overlap in the clinical and laboratory diagnosis of 
pneumonia and malaria  shown and that a three-day cotrimoxazole therapy is equally effective in treating both diseases 
as a combination of chloroquine and procaine is.  
   Since, the overlap in the clinical presentations is unaffected by the type of plasmodium and the risk for malaria and 
pneumonia are similar throughout the country, the results of this study can be generalized within Ethiopia to assist 
clinical management of children under 5 years old age.  
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